Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
MGZ Medical Genetics Center | RCV002290862 | SCV002580812 | uncertain significance | Hypertrophic cardiomyopathy 26 | 2022-02-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002382502 | SCV002668774 | uncertain significance | Cardiovascular phenotype | 2023-11-13 | criteria provided, single submitter | clinical testing | The p.V245M variant (also known as c.733G>A), located in coding exon 4 of the FLNC gene, results from a G to A substitution at nucleotide position 733. The valine at codon 245 is replaced by methionine, an amino acid with highly similar properties. This variant has been detected in a proband with skeletal myopathy whose relatives with this variant were reported to have features of skeletal myopathy or dilated cardiomyopathy (Velardo D et al. Front Neurol, 2022 Jul;13:930039). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
OMIM | RCV002284053 | SCV002573394 | pathogenic | Distal myopathy with posterior leg and anterior hand involvement | 2022-09-14 | no assertion criteria provided | literature only |